dianhydrogalactitol has been researched along with Cancer of Cervix in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, JA; Currie, JL; Homesley, HD; Stehman, FB; Yordan, EL | 1 |
| Barranco, SC; Costanzi, JJ; O'Quinn, AG | 1 |
| Blessing, JA; Blom, J; Ehrlich, CE; Mangan, C; Stehman, FB | 1 |
| Calanog, A; Camacho, F; Seltzer, V; Vogl, SE | 1 |
4 other study(ies) available for dianhydrogalactitol and Cancer of Cervix
| Article | Year |
|---|---|
Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Dianhydrogalactitol; Drug Evaluation; Female; Humans; Middle Aged; Sugar Alcohols; Uterine Cervical Neoplasms | 1984 |
Tumor cell kinetics-directed chemotherapy for advanced squamous carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Cycle; Dianhydrogalactitol; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1984 |
Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms | 1983 |
Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
Topics: Aged; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Sugar Alcohols; Uterine Cervical Neoplasms | 1982 |